[Neuropharmacological analysis of participation of the serotoninergic system in hyperalgesia in neurotized rats].
Kudriashova
M F
MF
I. P. Pavlov Institute of Physiology of the Russian Acad. Sci., St. Petersburg, Russia.
Andreev
B V
BV
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D002065:Buspirone / Q000494:pharmacology; D005473:Fluoxetine / Q000494:pharmacology; D006930:Hyperalgesia / Q000150:complications / Q000503:physiopathology*; D008297:Male; D008803:Mianserin / Q000494:pharmacology; D009497:Neurotic Disorders / Q000150:complications / Q000503:physiopathology*; D010147:Pain Measurement; D051381:Rats; D017207:Rats, Sprague-Dawley; D011985:Receptors, Serotonin / Q000187:drug effects; D044263:Receptors, Serotonin, 5-HT1; D012701:Serotonin / Q000502:physiology*; D012702:Serotonin Antagonists / Q000494:pharmacology; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D002065:Buspirone; D005473:Fluoxetine; D008803:Mianserin; D011985:Receptors, Serotonin; D044263:Receptors, Serotonin, 5-HT1; D012701:Serotonin; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors